Suppr超能文献

cT3-T4 期口腔鳞癌阳性切缘趋势。

Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.

机构信息

Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

University of Missouri School of Medicine, Columbia, Missouri, USA.

出版信息

Otolaryngol Head Neck Surg. 2023 Nov;169(5):1200-1207. doi: 10.1002/ohn.377. Epub 2023 May 26.

Abstract

OBJECTIVE

Positive surgical margins in oral cavity squamous cell carcinoma are associated with cost escalation, treatment intensification, and greater risk of recurrence and mortality. The positive margin rate has been decreasing for cT1-T2 oral cavity cancer over the past 2 decades. We aim to evaluate positive margin rates in cT3-T4 oral cavity cancer over time, and determine factors associated with positive margins.

STUDY DESIGN

Retrospective analysis of a national database.

SETTING

National Cancer Database 2004 to 2018.

METHODS

All adult patients diagnosed between 2004 and 2018 who underwent primary curative intent surgery for previously untreated cT3-T4 oral cavity cancer with known margin status were included. Logistic univariable and multivariable regression analyses were performed to identify factors associated with positive margins.

RESULTS

Among 16,326 patients with cT3 or cT4 oral cavity cancer, positive margins were documented in 2932 patients (18.1%). Later year of treatment was not significantly associated with positive margins (odds ratio [OR] 0.98, 95% confidence interval [CI] 0.96-1.00). The proportion of patients treated at academic centers increased over time (OR 1.02, 95% CI 1.01-1.03). On multivariable analysis, positive margins were significantly associated with hard palate primary, cT4 tumors, advancing N stage, lymphovascular invasion, poorly differentiated histology, and treatment at nonacademic or low-volume centers.

CONCLUSION

Despite increased treatment at academic centers for locally advanced oral cavity cancer, there has been no significant decrease in positive margin rates which remains high at 18.1%. Novel techniques for margin planning and assessment may be required to decrease positive margin rates in locally advanced oral cavity cancer.

摘要

目的

口腔鳞状细胞癌中的阳性切缘与成本增加、治疗强化以及复发和死亡风险增加有关。在过去的 20 年中,cT1-T2 口腔癌的阳性切缘率一直在下降。我们旨在评估随着时间的推移 cT3-T4 口腔癌的阳性切缘率,并确定与阳性切缘相关的因素。

研究设计

国家数据库的回顾性分析。

设置

2004 年至 2018 年国家癌症数据库。

方法

纳入 2004 年至 2018 年间接受首次未经治疗的 cT3-T4 口腔癌根治性手术且已知切缘状态的所有成年患者。进行逻辑单变量和多变量回归分析,以确定与阳性切缘相关的因素。

结果

在 16326 例 cT3 或 cT4 口腔癌患者中,有 2932 例(18.1%)记录到阳性切缘。治疗的后期年份与阳性切缘无显著相关性(比值比 [OR] 0.98,95%置信区间 [CI] 0.96-1.00)。治疗时间在学术中心的患者比例随着时间的推移而增加(OR 1.02,95%CI 1.01-1.03)。多变量分析显示,阳性切缘与硬腭原发、cT4 肿瘤、进展的 N 分期、淋巴血管侵犯、低分化组织学以及在非学术或低容量中心治疗显著相关。

结论

尽管学术中心对局部晚期口腔癌的治疗有所增加,但阳性切缘率仍未显著下降,仍高达 18.1%。可能需要新的切缘规划和评估技术来降低局部晚期口腔癌的阳性切缘率。

相似文献

1
Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg. 2023 Nov;169(5):1200-1207. doi: 10.1002/ohn.377. Epub 2023 May 26.
2
Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.
Laryngoscope. 2022 Oct;132(10):1962-1970. doi: 10.1002/lary.30033. Epub 2022 Feb 1.
4
Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases.
Otolaryngol Head Neck Surg. 2014 Dec;151(6):984-90. doi: 10.1177/0194599814551718. Epub 2014 Sep 25.
5
Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma.
J Otolaryngol Head Neck Surg. 2021 Jun 21;50(1):37. doi: 10.1186/s40463-021-00501-5.
7
Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.
Otolaryngol Head Neck Surg. 2018 Oct;159(4):675-682. doi: 10.1177/0194599818773070. Epub 2018 May 8.
8
Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma.
ORL J Otorhinolaryngol Relat Spec. 2023;85(6):348-359. doi: 10.1159/000534491. Epub 2023 Nov 15.
9
Margins in Laryngeal Squamous Cell Carcinoma Treated with Transoral Laser Microsurgery: A National Database Study.
Otolaryngol Head Neck Surg. 2019 Dec;161(6):986-992. doi: 10.1177/0194599819874315. Epub 2019 Sep 3.

引用本文的文献

1
Elective Neck Dissection in cT1-4 N0M0 Head and Neck Spindle Cell Carcinoma.
Otolaryngol Head Neck Surg. 2025 Aug;173(2):433-446. doi: 10.1002/ohn.1265. Epub 2025 Apr 21.
2
Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.
JAMA Otolaryngol Head Neck Surg. 2025 May 1;151(5):466-475. doi: 10.1001/jamaoto.2024.5250.
3
Volume Outcome Relationships of Oropharyngeal Cancer Patients Undergoing Transoral Robotic Surgery.
Laryngoscope. 2025 Aug;135(8):2810-2818. doi: 10.1002/lary.32098. Epub 2025 Mar 3.
4
Choice of Adjuvant Radiotherapy Facility in Sinonasal Squamous Cell Carcinoma.
Laryngoscope. 2025 Feb;135(2):705-715. doi: 10.1002/lary.31794. Epub 2024 Sep 24.
5
Primary site surgical resection in cM1 oral cavity squamous cell carcinoma.
Laryngoscope Investig Otolaryngol. 2024 Sep 14;9(5):e70000. doi: 10.1002/lio2.70000. eCollection 2024 Oct.
6
NK cell based immunotherapy against oral squamous cell carcinoma.
Front Immunol. 2024 Aug 13;15:1440764. doi: 10.3389/fimmu.2024.1440764. eCollection 2024.
7
Development of an augmented reality guidance system for head and neck cancer resection.
Healthc Technol Lett. 2023 Dec 7;11(2-3):93-100. doi: 10.1049/htl2.12062. eCollection 2024 Apr-Jun.
9
How Often is Cancer Present in Oral Cavity Re-resections After Initial Positive Margins?
Laryngoscope. 2024 Feb;134(2):717-724. doi: 10.1002/lary.30959. Epub 2023 Aug 16.

本文引用的文献

1
Trends in Positive Surgical Margins in cT1-T2 Oral Cavity Squamous Cell Carcinoma.
Laryngoscope. 2022 Oct;132(10):1962-1970. doi: 10.1002/lary.30033. Epub 2022 Feb 1.
2
Intraoperative Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma.
Laryngoscope. 2021 Mar;131(3):529-534. doi: 10.1002/lary.28822. Epub 2020 Jul 3.
3
Effect of Fluorescence Visualization-Guided Surgery on Local Recurrence of Oral Squamous Cell Carcinoma: A Randomized Clinical Trial.
JAMA Otolaryngol Head Neck Surg. 2020 Dec 1;146(12):1149-1155. doi: 10.1001/jamaoto.2020.3147.
5
Intraoperative Margin Assessment in Oral and Oropharyngeal Cancer Using Label-Free Fluorescence Lifetime Imaging and Machine Learning.
IEEE Trans Biomed Eng. 2021 Mar;68(3):857-868. doi: 10.1109/TBME.2020.3010480. Epub 2021 Feb 18.
6
Fluorescence lifetime imaging for intraoperative cancer delineation in transoral robotic surgery.
Transl Biophotonics. 2019 Dec;1(1-2). doi: 10.1002/tbio.201900017. Epub 2019 Oct 29.
7
Utility of intraoral ultrasound in managing oral tongue squamous cell carcinoma: Systematic review.
Laryngoscope. 2019 Mar;129(3):662-670. doi: 10.1002/lary.27403. Epub 2018 Aug 27.
8
Independent Predictors of Prognosis Based on Oral Cavity Squamous Cell Carcinoma Surgical Margins.
Otolaryngol Head Neck Surg. 2018 Oct;159(4):675-682. doi: 10.1177/0194599818773070. Epub 2018 May 8.
9
Positive Surgical Margins in the 10 Most Common Solid Cancers.
Sci Rep. 2018 Apr 9;8(1):5686. doi: 10.1038/s41598-018-23403-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验